EUVIMEDEUVIMED entdecken
Crossref

LncRNA Gm15834 Aggravates Cardiac Hypertrophy by Interacting with Sam68 and Activating NF-κB Mediated Inflammation

Yongsheng Liu, Man Jiang, Meitian Zhang, Yawen Xie, Lixin Wang, Pilong Shi, Qianlong Zhang, Qianhui Zhang, Kai Liu, Jiajun Zhou, Chao Song, Hongli Sun iD

Cardiovascular Drugs and Therapy · 2025

DOI: 10.1007/s10557-024-07569-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Drugs and Therapy, 2025. Verfasst von Yongsheng Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Harbin Medical University-Daqing, Daqing, Heilongjiang, 163319, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, NF-kappa B, Myocytes, Cardiac, RNA-Binding Proteins. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Heilongjiang Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiac hypertrophy is the common pathological process of multiple cardiovascular diseases. However, the molecular mechanisms of cardiac hypertrophy are unclear. Long non-coding RNA (lncRNA), a newly discovered type of transcript that has been demonstrated to function as crucial regulators in the development of cardiovascular diseases. This study revealed a novel regulatory pathway of lncRNA in cardiac hypertrophy. METHODS: The cardiac hypertrophy models were established by transverse aortic constriction (TAC) in mice and angiotensin II (Ang II) in HL-1 cardiomyocytes. Adeno-associated virus 9 (AAV9) in vivo and lncRNA Gm15834 and shRNA plasmids in vitro were used to overexpress and knock down lncRNA Gm15834. The myocardial tissue structure, cardiomyocyte area, cardiac function, protein expressions, and binding of lncRNA Gm15834 and Src-associated substrate during mitosis of 68 KDa (Sam68) were detected by hematoxylin and eosin (HE) staining, immunofluorescence staining, echocardiography, western blot and RNA immunoprecipitation (RIP), respectively. RESULTS: In cardiac hypertrophy models, inhibiting lncRNA Gm15834 could decrease Sam68 expression and nuclear factor kappa-B (NF-κB) mediated inflammatory activities in vivo and in vitro, but overexpressing lncRNA Gm15834 showed the opposite results. RIP experiments validated the binding activities between lncRNA Gm15834 and Sam68. Overexpression of Sam68 could counteract the anti-hypertrophy effects of lncRNA Gm15834 knockdown. Meanwhile, in vivo inhibition of lncRNA Gm15834 could inhibit Sam68 expression, reduce NF-κB mediated inflammatory activity and attenuate cardiac hypertrophy. CONCLUSION: Our study revealed a novel regulatory axis of cardiac hypertrophy, which comprised lncRNA Gm15834/Sam68/NF-κB/inflammation, shedding a new light for identifying therapy target of cardiac hypertrophy in clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingNF-kappa BMyocytes, CardiacRNA-Binding ProteinsAdaptor Proteins, Signal TransducingCardiomegalyInflammationDNA-Binding ProteinsInflammation MediatorsAnimalsDisease Models, AnimalMaleSignal TransductionMice, Inbred C57BLMiceCell LineVentricular Function, LeftVentricular Remodeling

Stichwörter der Autor:innen

Cardiac HypertrophyInflammationLncRNA Gm15834NF-κBSam68

Substanzen

RNA, Long NoncodingNF-kappa BRNA-Binding ProteinsAdaptor Proteins, Signal TransducingKhdrbs1 protein, mouseDNA-Binding ProteinsInflammation Mediators

Autor:innen und Institutionen

  • Department of Pharmacology, Harbin Medical University-Daqing, Daqing, Heilongjiang, 163319, China.
  • Department of Physiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, 163319, China.
  • Department of Pharmacology, Harbin Medical University-Daqing, Daqing, Heilongjiang, 163319, China. songchaooverload@163.com.
  • The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China. songchaooverload@163.com.
  • Department of Pharmacology, Harbin Medical University-Daqing, Daqing, Heilongjiang, 163319, China. sunhongli@hmudq.edu.cn.

ORCID-Profile: Hongli Sun

Förderung

  • Natural Science Foundation of Heilongjiang Province of China

Zitieren

APA

Liu, Y., Jiang, M., Zhang, M., Xie, Y., Wang, L., Shi, P., Zhang, Q., Zhang, Q., Liu, K., Zhou, J., Song, C., & Sun, H. (2025). LncRNA Gm15834 Aggravates Cardiac Hypertrophy by Interacting with Sam68 and Activating NF-κB Mediated Inflammation. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-024-07569-x

Vancouver

Liu Y, Jiang M, Zhang M, Xie Y, Wang L, Shi P, et al. LncRNA Gm15834 Aggravates Cardiac Hypertrophy by Interacting with Sam68 and Activating NF-κB Mediated Inflammation. Cardiovascular Drugs and Therapy. 2025. doi:10.1007/s10557-024-07569-x

BibTeX
@article{Liu2025,
  author = {Liu, Yongsheng and Jiang, Man and Zhang, Meitian and Xie, Yawen and Wang, Lixin and Shi, Pilong and Zhang, Qianlong and Zhang, Qianhui and Liu, Kai and Zhou, Jiajun and Song, Chao and Sun, Hongli},
  title = {LncRNA Gm15834 Aggravates Cardiac Hypertrophy by Interacting with Sam68 and Activating NF-κB Mediated Inflammation},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2025},
  doi = {10.1007/s10557-024-07569-x}
}
Kostenlos starten →